Silicon Laboratories SLAB
$220.21 −$1.34 (-0.60%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $221.29 +0.49%
Open$221.20
Prev close$221.55
Day range$219.98 – $221.93
Volume691.3K
Market cap$7.35B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Oct 2026
Revenue$250.89M+21.8% YoY
Operating profit$7.95M+164.4% YoY
Net profit$8.85M+189.1% YoY
Diluted EPS$0.26+186.7% YoY
Free cash flow$40.46M+44.9% YoY
Operating cash flow$46.78M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin61.3%
Operating margin-2.6%
Net margin-2.3%
Return on equity-1.9%
Return on assets-1.6%
Return on invested capital-2.5%
Current ratio4.60
Liabilities / assets15.8%
Cash & investments$439.84M
Net cash (debt)$439.84M
Free cash flow / sales0.8%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $250.89M | $228.19M | $213.50M | $784.76M | $208.21M |
| Total Operating Revenue | $250.89M | $228.19M | $213.50M | $784.76M | $208.21M |
| Cost of Revenue | $98.31M | $87.52M | $86.50M | $327.78M | $76.13M |
| Gross Profit | $152.58M | $140.67M | $127.00M | $456.98M | $132.08M |
| Operating Expense | $144.63M | $151.34M | $144.08M | $527.52M | $135.33M |
| Selling and Admin Expenses | $51.45M | $56.32M | $55.49M | $174.28M | $45.81M |
| -General & Admin Expense | $51.45M | – | – | – | – |
| Research & Development | $93.17M | $95.02M | $88.59M | $353.25M | $89.52M |
| Operating Profit | $7.95M | -$10.67M | -$17.08M | -$70.54M | -$3.25M |
| Net Non-Operating Interest Income (Expense) | $2.96M | $2.24M | $3.39M | $12.63M | $2.72M |
| Non-Operating Interest Income | $3.19M | $2.49M | $3.63M | $13.60M | $2.93M |
| Non-Operating Interest Expense | $226,000.00 | $251,000.00 | $232,000.00 | $975,000.00 | $214,000.00 |
| Pretax Profit | $10.91M | -$8.43M | -$13.69M | -$57.91M | -$534,000.00 |
| Tax | $2.06M | $2.16M | $2.21M | $7.00M | $2.15M |
| Net Profit | $8.85M | -$10.59M | -$15.90M | -$64.91M | -$2.68M |
| Profit from Continuing Operations | $8.85M | -$10.59M | -$15.90M | -$64.91M | -$2.68M |
| Net Income to Parent Company | $8.85M | -$10.59M | -$15.90M | -$64.91M | -$2.68M |
| Net Income to Common Stockholders | $8.85M | -$10.59M | -$15.90M | -$64.91M | -$2.68M |
| Basic EPS | $0.27 | -$0.32 | -$0.48 | -$1.98 | -$0.08 |
| Diluted EPS | $0.26 | -$0.32 | -$0.48 | -$1.98 | -$0.08 |
| – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.34B | $1.25B | $1.27B | $1.27B | $1.27B |
| Total Current Assets | $724.62M | $671.22M | $676.32M | $674.02M | $674.02M |
| Cash and Cash Equivalents & Short-Term Investments | $439.84M | $397.24M | $438.86M | $443.62M | $443.62M |
| -Cash and Cash Equivalents | $423.01M | $362.19M | $383.09M | $364.22M | $364.22M |
| -Short Term Investments | $16.83M | $35.05M | $55.77M | $79.40M | $79.40M |
| Receivables | $79.97M | $79.80M | $77.12M | $64.51M | $64.51M |
| -Accounts Receivable | $79.97M | $79.80M | $77.12M | $64.51M | $64.51M |
| Inventory | $133.39M | $123.34M | $103.23M | $95.57M | $95.57M |
| Other Current Assets | $71.42M | $70.84M | $57.11M | $70.32M | $70.32M |
| Total Non-Current Assets | $611.54M | $581.83M | $590.14M | $595.30M | $595.30M |
| Net PPE | $131.69M | $130.90M | $131.82M | $128.64M | $128.64M |
| Goodwill and Other Intangible Assets | $392.64M | $394.93M | $397.23M | $399.52M | $399.52M |
| -Goodwill | $376.39M | $376.39M | $376.39M | $376.39M | $376.39M |
| -Other Intangible Assets | $16.25M | $18.54M | $20.84M | $23.13M | $23.13M |
| Other Non-Current Assets | $87.21M | $56.00M | $61.09M | $67.14M | $67.14M |
| Total Liabilities | $210.77M | $158.25M | $167.93M | $174.90M | $174.90M |
| Total Current Liabilities | $157.51M | $124.15M | $132.48M | $143.79M | $143.79M |
| Payables | $68.86M | $52.41M | $56.38M | $51.94M | $51.94M |
| -Accounts Payable | $68.86M | $52.41M | $56.38M | $50.72M | $50.72M |
| Current Deferred Liabilities | $9.80M | $5.18M | $9.82M | $5.36M | $5.36M |
| Other Current Liabilities | $78.84M | $66.56M | $66.27M | $21.81M | $21.81M |
| Total Non-Current Liabilities | $53.27M | $34.11M | $35.45M | $31.11M | $31.11M |
| Other Non-Current Liabilities | $53.27M | $34.11M | $35.45M | $14.09M | $14.09M |
| Total Equity | $1.13B | $1.09B | $1.10B | $1.09B | $1.09B |
| Stockholders' Equity | $1.13B | $1.09B | $1.10B | $1.09B | $1.09B |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $206.20M | $184.46M | $177.55M | $157.40M | $157.40M |
| Retained Earnings | $919.18M | $910.33M | $920.92M | $936.81M | $936.81M |
| Gains/Losses Not Affecting Retained Earnings | $0.00 | $18,000.00 | $63,000.00 | $199,000.00 | $199,000.00 |
| -Gross PPE | – | – | – | $316.81M | $316.81M |
| -Accumulated Depreciation | – | – | – | -$188.17M | -$188.17M |
| -Total Tax Payable | – | – | – | $1.22M | $1.22M |
| Current Accrued Expenses | – | – | – | $14.20M | $14.20M |
| Short-Term Debt and Capital Lease Obligation | – | – | – | $6.93M | $6.93M |
| -Current Capital Lease Obligation | – | – | – | $6.93M | $6.93M |
| Long Term Debt and Capital Lease Obligation | – | – | – | $17.03M | $17.03M |
| -Long Term Capital Lease Obligation | – | – | – | $17.03M | $17.03M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $46.78M | -$14.51M | $4.93M | $95.71M | $8.35M |
| Net cash flow from continuing operations | $46.78M | -$14.51M | $4.93M | $95.71M | $8.35M |
| Net Income from Continuing Operations | $8.85M | -$10.59M | -$15.90M | -$64.91M | -$2.68M |
| Depreciation & Depletion & Amortization | $8.28M | $8.42M | $8.34M | $38.09M | $8.24M |
| Deferred Tax | $501,000.00 | $510,000.00 | $1.15M | $881,000.00 | -$1.15M |
| Change in Working Capital | $6.10M | -$38.50M | -$9.72M | $41.33M | -$16.74M |
| -Change in Receivables | -$164,000.00 | -$2.68M | -$12.61M | -$10.03M | $2.80M |
| -Change in Inventory | -$10.09M | -$20.12M | -$7.62M | $9.99M | -$13.32M |
| -Change in Prepaid Assets | -$34.41M | -$7.62M | $6.81M | $8.83M | -$254,000.00 |
| -Change in Payables and Accrued Expense | $16.32M | -$1.34M | $3.39M | $6.33M | -$4.81M |
| -Change in Other Current Liabilities | $29.81M | -$2.10M | -$4.16M | $23.92M | $1.94M |
| -Change In Other Working Capital | $4.63M | -$4.65M | $4.46M | $2.29M | -$3.09M |
| Net cash flow from investing | $15.30M | $12.35M | $14.89M | -$12.03M | $8.78M |
| Net Cash Flow from Continuing Investing Activities | $15.30M | $12.35M | $14.89M | -$12.03M | $8.78M |
| Net PPE Purchase and Sale | -$6.32M | -$12.32M | -$9.84M | -$29.92M | -$9.98M |
| Net Investment Purchase and Sale | $18.19M | $20.66M | $23.46M | $21.32M | $22.18M |
| Net Other Investing Changes | $3.43M | $4.01M | $1.27M | -$3.42M | – |
| Financing Cash Flow | -$1.26M | -$18.74M | -$956,000.00 | -$1.07M | $5.69M |
| Net Cash Flow from Continuing Financing Activities | -$1.26M | -$18.74M | -$956,000.00 | -$1.07M | $5.69M |
| Net Common Stock Issuance | $1,000.00 | – | – | $14.64M | $6.49M |
| Net Other Financing Charges | -$1.26M | -$26.50M | -$956,000.00 | -$15.71M | -$799,000.00 |
| Ending Cash Balance | $423.01M | $362.19M | $383.09M | $364.22M | $364.22M |
| Net Change in Cash | $60.82M | -$20.90M | $18.87M | $82.62M | $22.82M |
| Beginning Cash Balance | $362.19M | $383.09M | $364.22M | $281.61M | $341.40M |
| Free Cash Flow | $40.46M | -$26.83M | -$4.90M | $65.79M | -$1.63M |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on SLAB.
Sign in to join the discussion.